Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Advertising & Marketing

Sales

Legal & Regulatory

Acquisition & Integration

Goodwill impairment

Restructuring costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Teladoc

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002, by George Byron Brooks and Gary Wald and is headquartered in Purchase, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Teladoc reports solid Q4 growth, eyes revenue optimization strategies

Teladoc's Q4 performance showed revenue growth and margin focus, with BetterHelp contributing significantly to profitability.
The company's strategic focus on virtual care expansion and revenue optimization positions Teladoc for continued success in the healthcare market.
While facing internal restructuring challenges, Teladoc's emphasis on growth drivers and operational efficiency presents opportunities for future growth and market leadership.

Teladoc Health excels in Q1, eyes growth and efficiency

Teladoc Health's Q1 performance was strong, with revenue exceeding expectations.
The company is focused on efficiency, innovation, and driving value in virtual care.
BetterHelp segment showed growth and stability, with improving margins expected.
Opportunities exist to capitalize on ad pricing stability and consumer behavior trends.

Teladoc surpasses revenue expectations, focuses on innovation and growth

Teladoc's Q2 performance exceeded expectations, with strong revenue growth and improved margins in both segments. The company's strategic focus on whole-person care, weight management, and AI enhancements positions it well for future growth. Challenges include managing drug costs and private company valuations, while opportunities lie in virtual care demand and strategic M&A.
Teladoc's financial strength, commitment to innovation, and focus on efficiency improvements are key strengths driving its performance. The company's ability to navigate challenges and capitalize on opportunities in the evolving healthcare landscape underscores its resilience and growth potential.

Teladoc Health surpasses Q3 expectations, eyes margin expansion in '24

Teladoc Health's Q3 performance exceeded expectations, driven by revenue growth and margin improvements.
The company is focused on enhancing cost efficiencies, profitability, and driving margin expansion.
Stable pricing environment and strong client demand present opportunities for future growth.
Operational review and strategic initiatives position Teladoc for continued success in the healthcare sector.

Teladoc reports robust 2023 earnings, eyes growth amid marketing challenges

Teladoc delivered strong financial performance in 2023 with notable growth in adjusted EBITDA and revenue. The company faces challenges in BetterHelp marketing yields and delayed consumer engagement efforts.
However, Teladoc's strategic strengths lie in its long-term outlook for revenue growth, margin expansion, and cost-saving initiatives. Opportunities exist in optimizing sales force structure and capital deployment for future growth.
Overall, Teladoc's focus on profitability, growth optimization, and strategic capital allocation positions it well for sustained success in the telehealth industry.

Teladoc Health reports solid Q1 performance amidst revenue challenges

Teladoc Health's Q1 2024 performance showcased revenue growth in Integrated Care but challenges in BetterHelp segment revenue and margin management.
The company's financial strength, product portfolio, and cost initiatives position it well for growth opportunities and strategic market positioning.
Addressing challenges in ad spend management and focusing on international market efficiency are key to unlocking growth potential and improving financial performance.
Overall, Teladoc's performance, strengths, challenges, and opportunities reflect a dynamic landscape with strategic focus on sustainable growth and operational efficiency.

Teladoc Health reports Q2 revenue dip, EBITDA growth; addresses challenges

Teladoc Health's Q2 2024 performance showed mixed results with revenue decline but EBITDA growth. The company is leveraging strengths in patient safety and technology while addressing challenges in customer acquisition costs. Opportunities lie in operational efficiency, insurance coverage access, and international expansion.

Teladoc Health reports Q3 revenue decline but strategic growth

Teladoc Health's Q3 2024 performance reflects mixed results with revenue decline but strategic growth in the Integrated Care segment.
The company's focus on customer-centric strategies, technology, and clinical excellence positions it well for future success and market leadership.
Challenges in revenue decline and expense management require Teladoc Health to balance short-term financial performance with long-term growth objectives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.

Livongo Health Inc

In a sign of the growing importance and value of digital healthcare in the world of medicine, two of the industry’s publicly traded companies have agreed to a whopping $18.5 billion merger. The union of Teladoc Health, a provider of virtual care services, and Livongo, which has made a name for itself by integrating hardware […]

In a sign of digital health’s rise, Livongo and Teladoc Health agree to $18.5 billion merger

The largest U.S. telemedicine provider will acquire the leading applied health signals company for a combination of cash and stock.

Teladoc Health Merging with Livongo Health in Deal Worth $18.5 Billion

Teladoc Health early Wednesday announced it would acquire high-flying telehealth rival Livongo for about $18.5 billion.
The post Telemedicine High-Fliers Teladoc, Livongo Announce $18.5 Billion Merger appeared first on Investor's Business Daily.

Telemedicine High-Fliers Teladoc, Livongo Announce $18.5 Billion Merger

Teladoc Health Inc (NYSE: TDOC) shares are trading lower on Wednesday after the company announced a merger agreement with Livongo Health (NASDAQ: LVGO).

Teladoc, Livongo Health Merger Valued At $18.5B

Teladoc Health Inc. TDOC, -13.61% and Livongo Health Inc. LVGO, -5.26% said Wednesday they have agreed to merge in a deal valued at $18.5 billion to create a company that can serve a spectrum of health needs, using virtual care.

UPDATE: Teladoc and Livongo Health to merge in deal valued at $18.5 billion

Teladoc Health Inc. TDOC, +5.17% and Livongo Health Inc. LVGO, +5.78% said Wednesday they have agreed to merge in a deal valued at $18.5 billion to create a company that can serve a spectrum of health needs, using virtual care.

Teladoc and Livongo Health to merge in deal valued at $18.5 billion

Kinnevik AB (publ) (“Kinnevik”) today announced that it supports the proposed merger between Teladoc Health, Inc. (NYSE: TDOC) (“Teladoc Health”), the global leader in virtual care, and Livongo Health, Inc. (Nasdaq: LVGO) (“Livongo”), the leading Applied Health Signals company, creating the only consumer centered virtual care platform for a full spectrum of health needs. When the merger has been completed, Kinnevik will become an owner of a 4.5 percent stake in the combined company and receive USD 143m (SEK 1.3bn) in cash consideration. The merger consideration values Kinnevik’s stake in Livongo at approximately USD 2.0bn (SEK 17.6bn), up USD 183m (SEK 1.6bn) from the value of Kinnevik's stake in Livongo at 4 August 2020 close.

Kinnevik supports the proposed merger between Teladoc Health  and Livongo, and will own 4.5 percent of the combined company  plus receive USD 143 million in cash consideration

PURCHASE, NY and MOUNTAIN VIEW, Calif., Aug.  05, 2020  (GLOBE NEWSWIRE) -- Teladoc Health (TDOC), the global leader in virtual care, and Livongo (LVGO), the leading Applied Health Signals company – today announced that they have entered into a definitive merger agreement. This merger represents a transformational opportunity to improve the delivery, access and experience of healthcare for consumers around the world. The highly complementary organizations will combine to create substantial value across the healthcare ecosystem, enabling clients everywhere to offer high quality, personalized, technology-enabled longitudinal care that improves outcomes and lowers costs across the full spectrum of health. 

Teladoc Health and Livongo Merge to Create New Standard in Global Healthcare Delivery, Access and Experience

A new executive order from President Trump might benefit Teladoc.

Why Teladoc Stock Jumped on Tuesday

Teladoc Health (NASDAQ: TDOC) shares are trading higher after President Donald Trump on Monday announced an executive order to expand telehealth services in rural areas and said Medicare would cover additional telehealth services.

Why Teladoc Health's Stock Is Trading Higher

PayPal

Shopify

Each of these high flyers has the potential to generate game-changing returns in the coming years.

Got $3,000? Buy These 3 Monster Stocks in the Making

Avantor Inc.

Cognizant Technology Solutions

Equinix

Hologic

Lam Research

QUALCOMM

The last week of July is also the week that marks the peak of the earnings season.

8 Earnings Winners Seeing Major Analyst Upgrades for Even More Upside Ahead

Virtual care adoption is soaring amid the COVID-19 pandemic.

Why Teladoc Health Stock Jumped on Thursday

Anheuser-Busch InBev

Dine Brands Global

Fortune Brands Home & Security

Some positive trends are emerging this earnings season for semiconductors, telemedicine and buying online.

Earnings: Semiconductors and telemedicine killing it, buying online exploding

Teladoc's (TDOC) second-quarter results reflect higher revenues and solid rise in patient visits, partially offset by increased expenses.

Teladoc (TDOC) Q2 Earnings Lag Estimates, Revenues Up Y/Y

Advanced Micro Devices

Newmont Mining

If you have $1,000 to spare at the moment, these are some of the best companies to consider investing in now.
The post The 3 Best Stocks to Invest $1,000 in Now appeared first on InvestorPlace.

The 3 Best Stocks to Invest $1,000 in Now

Although revenue surged, the company was still deep in the red on the bottom line.

Teladoc Health Delivers a Mixed Q2 Report

The COVID-19 pandemic provided a powerful tailwind for the telehealth leader's Q2 results.

Teladoc Earnings: 5 Key Metrics Investors Should See

Revenue growth jumped as virtual visits on this company's telehealth platform soared. Can investors still get in on this hot stock?

Is Teladoc Stock a Buy After a Huge Second Quarter?

But the telehealth leader's revenue beat in the second quarter was definitely as great as it looked.

Why Teladoc Health's Q2 Earnings Miss Isn't As Bad As It Seems

Teladoc Health, Inc. (TDOC) CEO Jason Gorevic on Q2 2020 Results - Earnings Call Transcript

Teladoc (TDOC) earnings for the digital healthcare company's second quarter of 2020 have TDOC stock down after-hours Wednesday.
The post Teladoc Earnings: TDOC Stock Ticks Lower on Q2 EPS Miss appeared first on InvestorPlace.

Teladoc Earnings: TDOC Stock Ticks Lower on Q2 EPS Miss

ear-over-year Q2 revenue grows 85% to $241.0 million and total visits increase 203% to 2.8 million

Teladoc Health Reports Second-Quarter 2020 Results

LivePerson

Novocure

RingCentral

Splunk

Have you missed out on the rally of these 5 stocks in the past three years? LivePerson, Novocure, Splunk, RingCentral and Teladoc?

Missed Out On Rally Of These 5 Healthcare & Software Stocks? There May Still Be Time

Telehealth adoption has soared. How much will Teladoc benefit?

News for Teladoc Stock (TDOC)